Bausch Health reports Q1 2026 results; detailed figures not available in excerpt

Bausch Health Companies Inc.

2026-Q1 EPS reported -$3.82 revenue$2,524,000,000

Filing references earnings press release for quarter ended March 31, 2026, issued April 29, 2026.
The full press release (Exhibit 99.1) is referenced but not included in the provided text.
No revenue, EPS, segment data, or guidance figures can be extracted from the filing body alone.
Without the exhibit content, no specific financial metrics or trends can be summarized.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Bausch Health Companies Inc. reported financial results for the quarter ended March 31, 2026.

Period: the quarter ended March 31, 2026
Result: reported results

Exact text from the filing

Bausch Health Companies Inc. (the "Company") issued a press release announcing results of operations for the quarter ended March 31, 2026 and certain other financial information as of and for the quarter ended March 31, 2026.

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

Bausch Health Companies Inc. filing history →

Source: SEC EDGAR

accession 0000885590-26-000051

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.